scispace - formally typeset
M

Miao Miao

Researcher at Soochow University (Suzhou)

Publications -  94
Citations -  564

Miao Miao is an academic researcher from Soochow University (Suzhou). The author has contributed to research in topics: Hematopoietic stem cell transplantation & Transplantation. The author has an hindex of 10, co-authored 72 publications receiving 337 citations.

Papers
More filters
Journal ArticleDOI

Outcomes of Haploidentical Haematopoietic Stem Cell Transplantation for Paroxysmal Nocturnal Haemoglobinuria

TL;DR: The preliminary results indicated that haplo-HSCT is a feasible option for PNH patients lacking suitable identical donors, and two patients demonstrated delayed platelet recovery and one patient demonstrated platelet graft failure.
Journal ArticleDOI

[Lower risk myelodysplastic syndrome patients with transfusion dependent treated by dose-reduced decitabine].

TL;DR: Dose-reduced decitabine is well-tolerated and effective in transfusion dependent MDS patients in IPSS-lower risk and may prolong their survival time.
Journal ArticleDOI

A comparative study of porcine antihuman lymphocyte globulin versus antithymocyte globulin-fresenius in an allogeneic hematopoietic cell transplantation conditioning regimen for severe aplastic anemia.

TL;DR: In this article, the authors compared the outcomes of antihuman T lymphocyte globulin (ATG-F) and porcine antihuman lymphocyte Globulin (p-ALG) as part of a conditioning regimen in hematopoietic stem cell transplantation (HS...
Journal ArticleDOI

Comparison of haploidentical hematopoietic stem cell transplantation and matched-sibling donor transplantation for the treatment of paroxysmal nocturnal hemoglobinuria

TL;DR: It is indicated that haplo-HSCT was a feasible choice for PNH with favorable outcomes, and matched-sibling donor transplantation (MSD-HS CT) for paroxysmal nocturnal hemoglobinuria produced similar therapeutic efficacy.
Journal ArticleDOI

Identification of the Predictive Models for the Treatment Response of Refractory/Relapsed B-Cell ALL Patients Receiving CAR-T Therapy

TL;DR: These models established predictive models for treatment response estimation of CAR-T therapy and provided new clinical insights for the accurate diagnosis and targeted treatment of r/r B-ALL.